GI4 COST-EFFECTIVENESS OF TRIPLE THERAPIES OF ESOMEPRAZOLE AND RABEPRAZOLE FOR H. PYLORI ERADICATION IN THE PUBLIC SECTOR OF HONG KONG
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63166-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)63166-X/fulltext
Title :
GI4 COST-EFFECTIVENESS OF TRIPLE THERAPIES OF ESOMEPRAZOLE AND RABEPRAZOLE FOR H. PYLORI ERADICATION IN THE PUBLIC SECTOR OF HONG KONG
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63166-X&doi=10.1016/S1098-3015(10)63166-X
First page :
Section Title :
Open access? :
No
Section Order :
15